Beacon Capital Management LLC (Tennessee)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,170
Closed -$13.4K 951
2022
Q4
$13.4K Hold
1,170
﹤0.01% 444
2022
Q3
$12K Hold
1,170
﹤0.01% 436
2022
Q2
$19K Hold
1,170
﹤0.01% 407
2022
Q1
$19K Buy
+1,170
New +$19K ﹤0.01% 407